Bradykinin contributes to the systemic haemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure

  • Cruden, N. L.
  • Witherow, F. N.
  • Johnston, N. R.
  • Webb, D. J.
  • Fox, K. A. A.
  • Newby, D. E.

  • Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom

British Journal of Clinical Pharmacology 57(5):p 671-672, May 2004.
Copyright © 2004 Blackwell Publishing Ltd.